Literature DB >> 26604627

Frequency distribution of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among anemic patients in Saudi Arabia.

Mohieldin Elsayid1, Mohammed Jahman Al-Shehri1, Yasser Abdullah Alkulaibi1, Abdullah Alanazi2, Shoeb Qureshi3.   

Abstract

BACKGROUND: Notwithstanding, the growing incidence of sickle cell hemoglobinopathies (SCH) such as sickle cell anemia (SCA) or sickle cell disease, sickle/beta-thalassemia; the exact prevalence remains obscure in Saudi Arabia. Hence, this study is an attempt to determine the frequency of SCA and sickle cell trait (SCT) among all anemic patients with SCH treated at the King Abdul-Aziz Medical City (KAMC), Riyadh, Saudi Arabia. Furthermore, the hemoglobin (Hb) S and other Hb patterns (Hb AS and Hb F) were also estimated in SCA and SCT patients.
MATERIALS AND METHODS: Results of Hb capillary electrophoresis performed on all patients with SCH from January 2011 to December 2013 were evaluated retrospectively.
RESULTS: Of a total of 3332 patient data analyzed, 307 were anemic patients (58% males and 42% females) with SCH. The sickling test showed all the patients to be positive. Hb electrophoresis revealed the incidence of 96.7%, 3.3%, and 0% of the patients suffered from SCA, SCT and sickle/beta-thalassemia, respectively. Patients with SCA had a higher level of Hb F and showed no crisis when compared with other SCA patients who had lower or no Hb F levels.
CONCLUSION: SCA is relatively frequent among males (56.4%) than females out of all patients with SCH. The SCA incidence was more common (48.5%) among children, frequency of SCT among adult age group was 1.6%, while sickle/beta-thalassemia was 0%.

Entities:  

Keywords:  Fetal hemoglobin; sickle cell anemia; sickle cell hemoglobinopathies; sickle cell trait; sickle/beta-thalassemia

Year:  2015        PMID: 26604627      PMCID: PMC4630771          DOI: 10.4103/0976-9668.166093

Source DB:  PubMed          Journal:  J Nat Sci Biol Med        ISSN: 0976-9668


INTRODUCTION

Anemia is a condition in which the hemoglobin (Hb) concentration level is reduced. Sickle cell anemia is a disease of the blood, which is caused by an inherited Hb S gene.[1] Normal Hb consists of: Hb A, Hb A2 and Hb F, while a person with SCH has different Hb pattern.[2] In SCA the red blood cells are sickle or boat-shape.[3] Sickle Hb S is produced as a result of replacement of glutamic acid instead of valine in position number six of the β chain.[45] The abnormal red cells (sickle cells) can block small blood capillaries causing damage in tissues and organs, which leads to pain (crisis)[6789] increased extravascular destruction of red blood cells[10] and increased risk of severe dehydration.[11] SCA affects all age groups globally[1] with demographic variations. Children who are born with SCA inherit it from their parents. Persons who have the SCT or have SCA can be carriers of Hb S.[1213] Here, we determined the frequency distribution of SCA and SCT among anemic patients attending at KAMC - Riyadh, Saudi Arabia to assess the distribution of the disease and identify carriers among the population.

MATERIALS AND METHODS

A retrospective chart review study was conducted to determine the frequency of SCA and SCT among anemic Saudi Arabian patients. The study data were collected from hematology laboratory at KAMC, National Guard of Health Affairs Hospital complex in Riyadh, Saudi Arabia. Inclusion criteria: Male and female patients of all age groups who were diagnosed with anemia in the hematology laboratory from January 2011 to December 2013 were included. Exclusion criteria: Nonanemic patients or anemic patients with anemia other than SCH were excluded.

Data collection methods, instruments used, measurements

A computer printout of demographic data and discharge clinical events/outcomes collected from records department for all episodes of hospital discharges that were coded for diagnosis of SCA or SCT were analyzed.

Data analysis

Study variables were directly entered into SPSS software, version 20 (The International Business Machines Corporation, New York). A backup soft copy version, as well as a hard copy print, was dated, saved and secured after each data entry update. Statistical analysis of study variables was performed using SPSS software version 20. SCA, SCT frequency and clinical outcomes at discharge were determined.

RESULTS

Out of 3332 anemic patient's data analyzed, 307 were anemic patients with SCH. The results of Hb electrophoresis showed 297 (96.7%) SCA, 10 (3.3%) SCT and sick/beta-thalassemia patients (0%) [Figures 1 and 2]. Patients with SCA, who had high levels of Hb F did not have any crisis when compared with SCA patients with low or no Hb F levels [Table 1]. The SCA was highly frequent (56.4%) among males while among the females the incidence was 40.5% out of all patients with SCH [Tables 2 and 3]. In children, SCA was more commonly (48.5%) observed while SCT was only 1.0%. The frequency of SCA and SCT in adults was 36.25 and 1.6% respectively [Tables 4 and 5].
Figure 1

Frequency distribution of patients with hemoglobinopathies among anemic patients

Figure 2

Frequency of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among patients with sickle cell hemoglobinopathies

Table 1

Frequency of patient's crisis with respect to Hb patterns

Table 2

Frequency of Hb patterns among anemic patients with SCH

Table 3

Frequency of SCH with respect to gender

Table 4

Frequency of Hb patterns among SCA and SCT patients

Table 5

Frequency of SCA and SCT with respect to age groups

Frequency distribution of patients with hemoglobinopathies among anemic patients Frequency of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among patients with sickle cell hemoglobinopathies Frequency of patient's crisis with respect to Hb patterns Frequency of Hb patterns among anemic patients with SCH Frequency of SCH with respect to gender Frequency of Hb patterns among SCA and SCT patients Frequency of SCA and SCT with respect to age groups

DISCUSSION

Sickle cell hemoglobinopathies involve SCA, the SCT, and sickle/beta-thalassemia. SCA and SCT are most common forms of Hb defect (Hb S gene), which are inherited by children from parents.[1415] SCH is one of the common health problems globally and in Saudi Arabia, where the gene frequency of this disease is highly prevalent.[16171819] In our study, we focused on SCA, SCT and the Hb patterns in each type of hemoglobinopathies in addition to age and gender of patients. The study group included 307 anemic patients with SCH, the high frequency of SCA among SCH Saudi patients with homozygous sickle cell (Hb SS) and less frequent SCT with the heterozygous sickle cell (Hb AS). These proportions are consistent with previous reports.[2021] However, results of our study showed a high frequency of SCA (Hb SS) and SCT (Hb AS) among Saudi Arabian SCH patients. The high frequency of homozygous sickle cell (Hb SS) and heterozygous sickle cell (Hb AS) cases among the Saudi Arabian SCH population reflect the high frequency of Hb S gene, which may be due to consanguineous marriage, which is a common tribal tradition practice in this population.[2223] Additionally mild cases of SCA were also observed among adult patients. Some patients with SCA never had symptoms or crisis due to the presence of fetal Hb in high level.[24] Fetal Hb seems to protect the patients from disease severity and crisis. In our study, the majority of the SCA patients with (Hb SS) pattern had a severe crisis, and they tended to be more symptomatic. In contrast, the majority of SCA patients had (Hb S + Hb F) and these patients did not suffer from any crisis due to the presence of fetal Hb in an appropriate concentration.[2526] The level of fetal Hb in the blood circulation is very essential as they seem to protect the red blood cells from becoming sickle shape and hence prevent them from blocking the blood flow, especially in small capillaries.[26] We conclude that SCA is the most common type of hereditary anemia among the Saudi Arabian population. The distribution of Hb S among Saudi population illustrate that Hb AS predominates among family. High level of fetal Hb protects from disease crisis. The level of Hb S among individuals with SCA is gender and age independent. We recommend that family screening of the SCA and SCT is necessary to identify sickle cell carriers and should be extended to all areas, which have the high frequency of Hb S, and premarriage investigation should be considered as a routine investigation.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  17 in total

1.  Haplotypes of the beta-globin gene as prognostic factors in sickle-cell disease.

Authors:  M A el-Hazmi; A S Warsy; N Bashir; A Beshlawi; I R Hussain; S Temtamy; F Qubaili
Journal:  East Mediterr Health J       Date:  1999-11       Impact factor: 1.628

Review 2.  Managing sickle cell disease.

Authors:  Susan Claster; Elliott P Vichinsky
Journal:  BMJ       Date:  2003-11-15

3.  Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study.

Authors:  K J Wierenga; I R Hambleton; N A Lewis
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

4.  A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients.

Authors:  R L Bush; W C Pevec; J W Holcroft
Journal:  Am J Surg       Date:  1997-08       Impact factor: 2.565

5.  Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects.

Authors:  R P Perrine; M E Pembrey; P John; S Perrine; F Shoup
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

Review 6.  Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends.

Authors:  Frans J Smiers; Lakshmanan Krishnamurti; Guido Lucarelli
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

7.  Screening for sickle-cell trait in the emergency department.

Authors:  S W Wright; M H Zeldin; K Wrenn; O Miller
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

8.  Who counsels parents of newborns who are carriers of sickle cell anemia or cystic fibrosis?

Authors:  Kathryn L Moseley; Samya Z Nasr; Jane L Schuette; Andrew D Campbell
Journal:  J Genet Couns       Date:  2012-08-18       Impact factor: 2.537

9.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

Review 10.  Genetic epidemiology of the beta s gene.

Authors:  R L Nagel; A F Fleming
Journal:  Baillieres Clin Haematol       Date:  1992-04
View more
  7 in total

1.  Spectrum of Sickle Cell Diseases in Patients Diagnosed at a Tertiary Care Centre in Karnataka with Special Emphasis on their Clinicohaematological Profile.

Authors:  Hemalata Lokanatha; Pradeep Rudramurthy; Rajashekar Murthy G Ramachandrappa
Journal:  J Clin Diagn Res       Date:  2016-02-01

2.  Influence of Nutrition on Disease Severity and Health-related Quality of Life in Adults with Sickle Cell Disease: A Prospective Study.

Authors:  Sanaa Kamal; Moheyeldeen Mohamed Naghib; Jamaan Al Zahrani; Huda Hassan; Karim Moawad; Omar Arrahman
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

3.  First Experience in Living Liver Donation From Donors With Sickle Cell Trait.

Authors:  Maren Schulze; Ahmed Zidan; Mark Sturdevant; Sultan Aljudaibi; Mohammad Shagrani; Khalid Bzeizi; Saleh Alqahtani; Dieter C Broering
Journal:  Transplant Direct       Date:  2022-05-09

4.  Quantifying the Levels of Knowledge, Attitude, and Practice Associated with Sickle Cell Disease and Premarital Genetic Counseling in 350 Saudi Adults.

Authors:  Heba M Al-Qattan; Dana F Amlih; Fatima S Sirajuddin; Dalal I Alhuzaimi; Mai S Alageel; Reema M Bin Tuwaim; Farjah H Al Qahtani
Journal:  Adv Hematol       Date:  2019-05-02

5.  Cholelithiasis in patients with paediatric sickle cell anaemia in a Saudi hospital.

Authors:  Zakaria M Alhawsawi; Amna M Alshenqeti; Amal M Alqarafi; Leema K Alhussayen; Waheed A Turkistani
Journal:  J Taibah Univ Med Sci       Date:  2019-04-02

6.  Molecular Analysis of Xmn1-Polymorphic Site ´5 to Gγ of the β-Globin Gene Cluster in a Saudi Population of Jazan Region in Correlation with Hb F Expression.

Authors:  Abozer Y Elderdery; Abdullah Alsrhani; Badr Alzahrani; Muhammad Atif; Ahmed I Refaiy; Hussain Shiwani; Amin Abbas; Dawelbiet A Yahia
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

Review 7.  Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review.

Authors:  Reem A Hejazi; Nameer A Mandourah; Aryaf S Alsulami; Hussain T Bakhsh; Reem M Diri; Ahmad O Noor
Journal:  Saudi Pharm J       Date:  2021-02-16       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.